A Clinical, Pathological, and Genetic Characterization of Methotrexate-associated Lymphoproliferative Disorders

2013119 citationsJournal Articlebronze Open Access

Authors

Noriyuki Yamakawa · Center for Genomic Science

Masakazu Fujimoto · Center for Genomic Science

Daisuke Kawabata · Center for Genomic Science

Chikashi Terao · Center for Genomic Science

Momoko Nishikori · Kyoto University

Ran Nakashima · Center for Genomic Science

Yoshitaka Imura

Abstract

Our data demonstrate that patients in the EBVMCU, a specific clinical subgroup of MTX-LPD, had a better clinical outcome when MTX was withdrawn than did other patients with MTX-LPD.

Topics & Keywords

Viral-associated cancers and disorders Lymphoma Diagnosis and Treatment Parvovirus B19 Infection Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The Journal of Rheumatology

Volume 41, Issue 2, pp. 293-299

DOI: 10.3899/jrheum.130270

Field-Weighted Citation Impact: 3.08